• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早期乳腺癌生存质量的社会经济不平等的幅度和时间变化:来自多中心法国 CANTO 队列的研究结果。

Magnitude and Temporal Variations of Socioeconomic Inequalities in the Quality of Life After Early Breast Cancer: Results From the Multicentric French CANTO Cohort.

机构信息

Unit of Population Epidemiology, Division of Primary Care, Department of Health and Community Medicine, Geneva University Hospitals and Faculty of Medicine, University of Geneva, Geneva, Switzerland.

Division of Oncology, Department of Oncology, Geneva University Hospitals, Geneva, Switzerland.

出版信息

J Clin Oncol. 2024 Aug 20;42(24):2908-2917. doi: 10.1200/JCO.23.02099. Epub 2024 Jun 18.

DOI:10.1200/JCO.23.02099
PMID:38889372
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11328924/
Abstract

PURPOSE

Socioeconomic status (SES) influences the survival outcomes of patients with early breast cancer (EBC). However, limited research investigates social inequalities in their quality of life (QoL). This study examines the socioeconomic inequalities in QoL after an EBC diagnosis and their time trends.

PATIENTS AND METHODS

We used data from the French prospective multicentric CANTO cohort (ClinicalTrials.gov identifier: NCT01993498), including women with EBC enrolled between 2012 and 2018. QoL was assessed using the European Organisation for Research and Treatment of Cancer QoL Core 30 questionnaire (QLQ-C30). summary score at diagnosis and 1 and 2 years postdiagnosis. We considered three indicators of SES separately: self-reported financial difficulties, household income, and educational level. We first analyzed the trajectories of the QLQ-C30 summary score by SES group. Then, social inequalities in QLQ-C30 summary score and their time trends were quantified using the regression-based slope index of inequality (SII), representing the absolute change in the outcome along socioeconomic gradient extremes. The analyses were adjusted for age at diagnosis, Charlson Comorbidity Index, disease stage, and type of local and systemic treatment.

RESULTS

Among the 5,915 included patients with data on QoL at diagnosis and at the 2-year follow-up, social inequalities in QLQ-C30 summary score at baseline were statistically significant for all SES indicators (SII = -7.6 [-8.9; -6.2], SII = -4.0 [-5.2; -2.8]), SII = -1.9 [-3.1; -0.7]). These inequalities significantly increased (interaction < .05) in year 1 and year 2 postdiagnosis, irrespective of prediagnosis health, tumor characteristics, and treatment. Similar results were observed in subgroups defined by menopausal status and type of adjuvant systemic treatment.

CONCLUSION

The magnitude of preexisting inequalities in QoL increased over time after EBC diagnosis, emphasizing the importance of considering social determinants of health during comprehensive cancer care planning.

摘要

目的

社会经济地位(SES)影响早期乳腺癌(EBC)患者的生存结局。然而,关于生活质量(QoL)方面的社会不平等问题,相关研究还很有限。本研究旨在探讨 EBC 诊断后 QoL 方面的社会经济不平等及其时间趋势。

患者和方法

我们使用了法国前瞻性多中心 CANTO 队列(ClinicalTrials.gov 标识符:NCT01993498)的数据,该队列纳入了 2012 年至 2018 年间确诊的 EBC 女性患者。使用欧洲癌症研究与治疗组织生活质量核心 30 问卷(QLQ-C30)评估 QoL。在诊断时和诊断后 1 年和 2 年评估 QLQ-C30 总评分。我们分别考虑了 SES 的三个指标:自我报告的经济困难、家庭收入和教育水平。我们首先分析了按 SES 分组的 QLQ-C30 总评分的轨迹。然后,使用基于回归的不平等斜率指数(SII)量化了 QLQ-C30 总评分的社会不平等及其时间趋势,该指数代表了沿着社会经济梯度极值的结局的绝对变化。分析调整了诊断时的年龄、Charlson 合并症指数、疾病分期以及局部和全身治疗类型。

结果

在纳入的 5915 名有诊断时和 2 年随访时 QoL 数据的患者中,所有 SES 指标的 QLQ-C30 总评分的基线社会不平等均具有统计学意义(SII=-7.6[-8.9;-6.2],SII=-4.0[-5.2;-2.8]),SII=-1.9[-3.1;-0.7])。在诊断后 1 年和 2 年,无论预测前健康状况、肿瘤特征和治疗情况如何,这些不平等均显著增加(交互作用<.05)。在绝经状态和辅助全身治疗类型定义的亚组中也观察到了类似的结果。

结论

EBC 诊断后,预先存在的 QoL 不平等程度随着时间的推移而增加,这强调了在全面癌症护理计划中考虑健康的社会决定因素的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b553/11328924/b0264cce883f/jco-42-2908-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b553/11328924/2af80cf000d9/jco-42-2908-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b553/11328924/cc96c6e61647/jco-42-2908-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b553/11328924/95bfeadec43d/jco-42-2908-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b553/11328924/b0264cce883f/jco-42-2908-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b553/11328924/2af80cf000d9/jco-42-2908-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b553/11328924/cc96c6e61647/jco-42-2908-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b553/11328924/95bfeadec43d/jco-42-2908-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b553/11328924/b0264cce883f/jco-42-2908-g005.jpg

相似文献

1
Magnitude and Temporal Variations of Socioeconomic Inequalities in the Quality of Life After Early Breast Cancer: Results From the Multicentric French CANTO Cohort.早期乳腺癌生存质量的社会经济不平等的幅度和时间变化:来自多中心法国 CANTO 队列的研究结果。
J Clin Oncol. 2024 Aug 20;42(24):2908-2917. doi: 10.1200/JCO.23.02099. Epub 2024 Jun 18.
2
[Increasing social inequalities in quality of life after early breast cancer].[早期乳腺癌后生活质量方面日益加剧的社会不平等现象]
Med Sci (Paris). 2025 Apr;41(4):380-383. doi: 10.1051/medsci/2025041. Epub 2025 Apr 28.
3
Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: a prospective patient-reported outcomes analysis.内分泌治疗和化疗对乳腺癌幸存者生活质量的影响差异:一项前瞻性患者报告结局分析。
Ann Oncol. 2019 Nov 1;30(11):1784-1795. doi: 10.1093/annonc/mdz298.
4
Quality of life of women with a screen-detected versus clinically detected breast cancer in the Netherlands: a prospective cohort study.荷兰筛查发现与临床诊断出乳腺癌的女性的生活质量:一项前瞻性队列研究。
Qual Life Res. 2025 Jan;34(1):161-171. doi: 10.1007/s11136-024-03783-0. Epub 2024 Sep 17.
5
Social inequalities in quality of life in a cohort of women diagnosed with breast cancer in Barcelona (DAMA Cohort).巴塞罗那乳腺癌确诊女性队列中的生活质量社会不平等现象(DAMA队列)
Cancer Epidemiol. 2018 Jun;54:38-47. doi: 10.1016/j.canep.2018.03.007. Epub 2018 Mar 21.
6
Dynamics of Long-Term Patient-Reported Quality of Life and Health Behaviors After Adjuvant Breast Cancer Chemotherapy.辅助乳腺癌化疗后长期患者报告的生活质量和健康行为的动态变化。
J Clin Oncol. 2022 Sep 20;40(27):3190-3204. doi: 10.1200/JCO.21.00277. Epub 2022 Apr 21.
7
Socioeconomic status and quality of life in patients with locally advanced head and neck cancer.社会经济地位与局部晚期头颈部癌症患者的生活质量。
Strahlenther Onkol. 2018 Aug;194(8):737-749. doi: 10.1007/s00066-018-1305-3. Epub 2018 May 7.
8
Factors associated with enrolment in clinical trials among women with early-stage breast cancer.早期乳腺癌女性参与临床试验的相关因素。
ESMO Open. 2022 Jun;7(3):100513. doi: 10.1016/j.esmoop.2022.100513. Epub 2022 Jun 17.
9
Bridging the Age Gap in breast cancer: Impact of chemotherapy on quality of life in older women with early breast cancer.跨越乳腺癌的年龄差距:化疗对早期乳腺癌老年女性生活质量的影响。
Eur J Cancer. 2021 Feb;144:269-280. doi: 10.1016/j.ejca.2020.11.022. Epub 2020 Dec 26.
10
Capivasertib and fulvestrant for patients with hormone receptor-positive, HER2-negative advanced breast cancer (CAPItello-291): patient-reported outcomes from a phase 3, randomised, double-blind, placebo-controlled trial.卡培他滨联合氟维司群治疗激素受体阳性、HER2 阴性晚期乳腺癌患者(CAPItello-291):一项随机、双盲、安慰剂对照的 3 期临床试验的患者报告结局。
Lancet Oncol. 2024 Sep;25(9):1231-1244. doi: 10.1016/S1470-2045(24)00373-5.

引用本文的文献

1
Five-year conditional relative survival up to 10 years post-diagnosis among adolescent and young adult breast cancer patients by age, stage, and receptor subtype.青少年及年轻成人乳腺癌患者按年龄、分期和受体亚型划分的诊断后长达10年的5年条件相对生存率。
J Natl Cancer Cent. 2025 Mar 31;5(3):297-305. doi: 10.1016/j.jncc.2025.01.005. eCollection 2025 Jun.
2
Regression analysis and validation of risk factors for upper limb dysfunction following modified radical mastectomy for breast cancer patients.乳腺癌患者改良根治术后上肢功能障碍危险因素的回归分析及验证
Am J Transl Res. 2025 Apr 15;17(4):2614-2628. doi: 10.62347/CZYA6232. eCollection 2025.
3

本文引用的文献

1
Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.早期乳腺癌:ESMO 诊断、治疗及随访临床实践指南
Ann Oncol. 2024 Feb;35(2):159-182. doi: 10.1016/j.annonc.2023.11.016. Epub 2023 Dec 13.
2
Quality of life in the adjuvant setting: A meta-analysis of US Food and Drug Administration approved anti-cancer drugs from 2018 to 2022.辅助治疗环境下的生活质量:对 2018 年至 2022 年美国食品和药物管理局批准的抗癌药物的荟萃分析。
J Cancer Policy. 2023 Sep;37:100426. doi: 10.1016/j.jcpo.2023.100426. Epub 2023 Jun 2.
3
Minimally important differences for interpreting EORTC QLQ-C30 change scores over time: A synthesis across 21 clinical trials involving nine different cancer types.
Female Breast Cancer Incidence and Association with Socioeconomic Status in a Population-Based Cohort - China, 2018-2024.
基于人群队列的中国2018 - 2024年女性乳腺癌发病率及其与社会经济地位的关联
China CDC Wkly. 2025 Mar 7;7(10):341-346. doi: 10.46234/ccdcw2025.055.
4
A Life course approach to investigate breast cancer and migration in the greater Paris area: the SENOVIE study protocol.一项采用生命历程方法对大巴黎地区乳腺癌与移民情况进行调查的研究:SENOVIE研究方案。
BMJ Open. 2025 Apr 2;15(4):e095759. doi: 10.1136/bmjopen-2024-095759.
5
The impact of adverse childhood experiences on pain and subjective cognitive decline in patients treated for localized breast cancer: The mediating role of sense of coherence, sense of danger and psychosocial distress and danger.童年不良经历对局部乳腺癌患者疼痛及主观认知衰退的影响:连贯感、危险感、心理社会困扰及危险感的中介作用
Breast. 2025 Apr;80:103884. doi: 10.1016/j.breast.2025.103884. Epub 2025 Jan 17.
6
Atherosclerosis and the Bidirectional Relationship Between Cancer and Cardiovascular Disease: From Bench to Bedside, Part 2 Management.动脉粥样硬化与癌症和心血管疾病的双向关系:从实验台到病床边,第2部分 管理
Int J Mol Sci. 2025 Jan 2;26(1):334. doi: 10.3390/ijms26010334.
7
Gerotherapeutics: aging mechanism-based pharmaceutical and behavioral interventions to reduce cancer racial and ethnic disparities.老年治疗学:基于衰老机制的药物和行为干预措施,以减少癌症方面的种族和民族差异。
J Natl Cancer Inst. 2025 Mar 1;117(3):406-422. doi: 10.1093/jnci/djae211.
最小有意义变化值在解读 EORTC QLQ-C30 时间变化评分中的作用:跨越涉及 9 种不同癌症类型的 21 项临床试验的综合研究
Eur J Cancer. 2023 Jul;188:171-182. doi: 10.1016/j.ejca.2023.04.027. Epub 2023 May 7.
4
Impact of adjuvant trastuzumab treatment on fatigue, emotional status and quality of personal and work life of patients with localised breast cancer: results of the 'HER-ception' study.辅助曲妥珠单抗治疗对局限性乳腺癌患者疲劳、情绪状态及个人和工作生活质量的影响:“HER-ception”研究结果。
Support Care Cancer. 2022 Dec 16;31(1):38. doi: 10.1007/s00520-022-07512-6.
5
Socioeconomic inequalities in HRQoL in England: an age-sex stratified analysis.英格兰生命质量的社会经济不平等:按年龄-性别分层分析。
Health Qual Life Outcomes. 2022 Aug 2;20(1):121. doi: 10.1186/s12955-022-02024-7.
6
Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.《NCCN 肿瘤学临床实践指南:乳腺癌》第 3.2022 版
J Natl Compr Canc Netw. 2022 Jun;20(6):691-722. doi: 10.6004/jnccn.2022.0030.
7
Evidence-based approaches for the management of side-effects of adjuvant endocrine therapy in patients with breast cancer.基于证据的方法用于管理乳腺癌辅助内分泌治疗的副作用。
Lancet Oncol. 2021 Jul;22(7):e303-e313. doi: 10.1016/S1470-2045(20)30666-5. Epub 2021 Apr 20.
8
Quality of Life in a Cohort of 1078 Women Diagnosed with Breast Cancer in Spain: 7-Year Follow-Up Results in the MCC-Spain Study.1078 例西班牙女性乳腺癌患者的生活质量:MCC-Spain 研究 7 年随访结果。
Int J Environ Res Public Health. 2020 Nov 13;17(22):8411. doi: 10.3390/ijerph17228411.
9
Minimally Important Differences for Interpreting EORTC QLQ-C30 Scores in Patients With Advanced Breast Cancer.晚期乳腺癌患者中用于解释欧洲癌症研究与治疗组织核心生活质量问卷C30评分的最小重要差异
JNCI Cancer Spectr. 2019 Jun 4;3(3):pkz037. doi: 10.1093/jncics/pkz037. eCollection 2019 Sep.
10
Impact of Breast Cancer Treatment on Employment: Results of a Multicenter Prospective Cohort Study (CANTO).乳腺癌治疗对就业的影响:一项多中心前瞻性队列研究(CANTO)的结果
J Clin Oncol. 2020 Mar 1;38(7):734-743. doi: 10.1200/JCO.19.01726. Epub 2019 Dec 13.